Essential role of the N-terminal region of TFII-I in viability and behavior

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Lucena, Jaume ^a   Pezzi, Susana ^a   Aso, Ester ^a   Valero, Maria C ^b   Carreiro, Candelas ^c   Dubus, Pierre ^d   Sampaio, Adriana ^e   Segura, Maria ^a,f   Barthelemy, Isabel ^c   Zindel, Marc Y ^a,f   Sousa, Nuno ^e   Barbero, José L ^g   Maldonado, Rafael ^a   Pérez Jurado, Luis A ^a,f,h   Campuzano, Victoria ^a,f  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e UNIVERSITY OF MINHO   (Portugal)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^g CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR II; TRANSCRIPTION FACTOR II I; UNCLASSIFIED DRUG; GTF2I PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 7Q; COGNITION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; EMBRYO; EMBRYO DEVELOPMENT; FERTILITY; FETUS; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GROWTH RETARDATION; HETEROZYGOSITY; HOMOZYGOSITY; IN VIVO STUDY; LOUDNESS RECRUITMENT; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; WILLIAMS BEUREN SYNDROME; ANIMAL; COGNITIVE DEFECT; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MOUSE MUTANT; MULTIPLE MALFORMATION SYNDROME; PHYSIOLOGY;

MUS;

ABNORMALITIES, MULTIPLE; ANIMALS; COGNITION DISORDERS; CRANIOFACIAL ABNORMALITIES; HETEROZYGOTE; HOMOZYGOTE; HYPERACUSIS; MICE; MICE, MUTANT STRAINS; PHENOTYPE; SEQUENCE DELETION; TRANSCRIPTION FACTORS, TFII; WILLIAMS SYNDROME;

EID: 77950920677     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-61     Document Type: Article

References (25)

1. Bayes M, Magano LF, Rivera N, Flores R, Perez Jurado LA. Mutational mechanisms of Williams-Beuren syndrome deletions. American journal of human genetics 2003, 73(1):131-151. 10.1086/376565, 1180575, 12796854.
2. Perez Jurado LA, Wang YK, Peoples R, Coloma A, Cruces J, Francke U. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK. Human molecular genetics 1998, 7(3):325-334. 10.1093/hmg/7.3.325, 9466987.
3. Perez Jurado AL. Williams-Beuren syndrome: a model of recurrent genomic mutation. Hormone research 2003, 59(Suppl 1):106-113. 10.1159/000067836, 12638521.
4. Meyer-Lindenberg A, Mervis CB, Berman KF. Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behaviour. Nature reviews 2006, 7(5):380-393. 10.1038/nrn1906, 16760918.
5. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, Keating MT. Elastin is an essential determinant of arterial morphogenesis. Nature 1998, 393(6682):276-280. 10.1038/30522, 9607766.
6. Hirota H, Matsuoka R, Chen XN, Salandanan LS, Lincoln A, Rose FE, Sunahara M, Osawa M, Bellugi U, Korenberg JR. Williams syndrome deficits in visual spatial processing linked to GTF2IRD1 and GTF2I on chromosome 7q11.23. Genet Med 2003, 5(4):311-321. 10.1097/01.GIM.0000076975.10224.67, 12865760.
7. Morris CA, Mervis CB, Hobart HH, Gregg RG, Bertrand J, Ensing GJ, Sommer A, Moore CA, Hopkin RJ, Spallone PA, et al. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region. American journal of medical genetics 2003, 123A(1):45-59. 10.1002/ajmg.a.20496, 14556246.
8. Edelmann L, Prosnitz A, Pardo S, Bhatt J, Cohen N, Lauriat T, Ouchanov L, Gonzalez PJ, Manghi ER, Bondy P, et al. An atypical deletion of the Williams-Beuren syndrome interval implicates genes associated with defective visuospatial processing and autism. Journal of medical genetics 2007, 44(2):136-143. 10.1136/jmg.2006.044537, 2598069, 16971481.
9. Dai L, Bellugi U, Chen XN, Pulst-Korenberg AM, Jarvinen-Pasley A, Tirosh-Wagner T, Eis PS, Graham J, Mills D, Searcy Y, et al. Is it Williams syndrome? GTF2IRD1 implicated in visual-spatial construction and GTF2I in sociability revealed by high resolution arrays. American journal of medical genetics 2009, 149A(3):302-314. 10.1002/ajmg.a.32652, 2650741, 19205026.
10. Tassabehji M, Hammond P, Karmiloff-Smith A, Thompson P, Thorgeirsson SS, Durkin ME, Popescu NC, Hutton T, Metcalfe K, Rucka A, et al. GTF2IRD1 in craniofacial development of humans and mice. Science 2005, 310(5751):1184-1187. 10.1126/science.1116142, 16293761.
11. Young EJ, Lipina T, Tam E, Mandel A, Clapcote SJ, Bechard AR, Chambers J, Mount HT, Fletcher PJ, Roder JC, et al. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes, brain, and behavior 2008, 7(2):224-234. 10.1111/j.1601-183X.2007.00343.x, 17680805.
12. Enkhmandakh B, Makeyev AV, Erdenechimeg L, Ruddle FH, Chimge NO, Tussie-Luna MI, Roy AL, Bayarsaihan D. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(1):181-186. 10.1073/pnas.0811531106, 2629217, 19109438.
13. Li HH, Roy M, Kuscuoglu U, Spencer CM, Halm B, Carlsmith Harrison K, Bayle JH, Splendore A, Ding F, Meltzer LA, et al. Induced chromosome deletions cause hypersociability and other features of Williams-Beuren Syndrome in Mice. EMBO Molecular Medicine 2009, 1:50-65. 10.1002/emmm.200900003, 20049703.
14. Roy AL. Signal-induced functions of the transcription factor TFII-I. Biochimica et biophysica acta 2007, 1769(11-12):613-621. 2140948, 17976384.
15. Pantoja C, Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999, 18(35):4974-4982. 10.1038/sj.onc.1202880, 10490832.
16. Todaro GJ, Green H. Simian virus 40 transformation and the period of cellular deoxyribonucleic acid synthesis. J Virol 1967, 1(1):115-119. 10.1099/0022-1317-1-1-115, 375511, 4318942.
17. Keuker J. How to use the optical fractionator:an example based on the estimation of neurons in the hippocampal CA1 and CA3 regions of tree shrews. Brain Res Protoc 2001, 7:211-221.
18. Cheriyath V, Roy AL. Structure-function analysis of TFII-I. Roles of the N-terminal end, basic region, and I-repeats. J Biol Chem 2001, 276(11):8377-8383. 10.1074/jbc.M008411200, 11113127.
19. Tapia-Paez I, Tammimies K, Massinen S, Roy AL, Kere J. The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia. Faseb J 2008, 22(8):3001-3009. 10.1096/fj.07-104455, 2493457, 18445785.
20. Roy AL. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I. Gene 2001, 274(1-2):1-13. 10.1016/S0378-1119(01)00625-4, 11674993.
21. Hakre S, Tussie-Luna MI, Ashworth T, Novina CD, Settleman J, Sharp PA, Roy AL. Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression. Mol Cell 2006, 24(2):301-308. 10.1016/j.molcel.2006.09.005, 17052463.
22. Desgranges ZP, Ahn J, Lazebnik MB, Ashworth T, Lee C, Pestell RC, Rosenberg N, Prives C, Roy AL. Inhibition of TFII-I-dependent cell cycle regulation by p53. Mol Cell Biol 2005, 25(24):10940-10952. 10.1128/MCB.25.24.10940-10952.2005, 1316948, 16314517.
23. van Hagen JM, Geest JN, Giessen RS, Lagers-van Haselen GC, Eussen HJ, Gille JJ, Govaerts LC, Wouters CH, de Coo IF, Hoogenraad CC, et al. Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome. Neurobiol Dis 2007, 26(1):112-124. 10.1016/j.nbd.2006.12.009, 17270452.
24. Levitin DJ, Cole K, Chiles M, Lai Z, Lincoln A, Bellugi U. Characterizing the musical phenotype in individuals with Williams Syndrome. Child Neuropsychol 2004, 10(4):223-247.
25. Hickok G, Bellugi U, Jones W. Asymmetrical ability. Science 1995, 270(5234):219-220.